Global Pediatric Perfusion Systems Market Insights Forecasts to 2033

• The Global Pediatric Perfusion Systems Market Size was Valued at USD 578.3 Million in 2023
• The Market Size is Growing at a CAGR of 6.90% from 2023 to 2033
• The Worldwide Pediatric Perfusion Systems Market Size is Expected to Reach USD 1127.3 Million by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

 

Get more details on this report -

Request Free Sample PDF

 

The Global Pediatric Perfusion Systems Market Size is Anticipated to Exceed USD 1127.3 Million by 2033, Growing at a CAGR of 6.90% from 2023 to 2033.

 

Market Overview

The term pediatric perfusion systems describe a particular method of performing extracorporeal circulation and cardiopulmonary bypass during heart surgery on newborns and pediatric patients. To maintain blood flow and oxygenation to the body when a child’s lungs or heart are unable to function properly, the heart-lung machine and related equipment are used. This operation is critical in treating congenital heart defects, which are systemic problems at birth, as well as pediatric cardiac conditions that require essential surgical intervention. Trained professionals are required to handle this sophisticated device, and they play an important role in the successful completion of pediatric cardiac surgery. The equipment and procedures used in pediatric perfusion are particularly designed to be more precise and kind because of the smaller size and special physiological characteristics of pediatric children as compared to adult perfusion techniques. To handle this technique, highly qualified professionals are needed due to the complexities and elegance involved in managing the circulatory requirements of children and securing their safety throughout the surgical procedure. The main products used in pediatric perfusion systems involve heart-lung machines, oxygenators, pumps, cannulas, and tubing tests. Heart-lung machine merging a pump and oxygenator to provide and oxygenate a child's blood outside their body during surgery. Oxygenators permeate oxygen and remove carbon dioxide from the blood. Pumps are important to direct blood flow via the circuit, while cannula provide a vascular access point. Tubing sets connect all parts to form a fully-merged perfusion circuit. Additionally, the increasing number of surgical operations performed on children is anticipated to drive the growth of the market over the predicted timeframe.

 

Report Coverage

This research report categorizes the market for the global pediatric perfusion systems market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global pediatric perfusion systems market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global pediatric perfusion systems market.

 

Driving Factors

The rising cases of cardiovascular disorders in children are expected to boost the growth of the market. The increase in cardiac conditions required a higher volume of surgical operations, directly raising the demand for perfusion techniques. The rising complications of congenital heart surgeries need advanced perfusion techniques and equipment, propelling market growth. Rising government inventiveness and funding are crucial factors that are predicted to fuel the growth of the pediatric perfusion market. The exposure of advanced technology in pediatric perfusion is certainly a huge driving force for market growth. As expected, advancements in technology are a strong catalyst fueling the pediatric perfusion market. With the on-going progress of technology in healthcare, the abilities of perfusion systems are increasing, especially in the area of pediatric care. These factors are driving the growth of the pediatric perfusion systems market over the predicted timeframe.

 

Restraining Factors

The risks related to pediatric perfusion methods can create a challenge to the growth of the pediatric perfusion systems market. Possible risks during pediatric perfusion process include blood clots, bleeding, infection, and organ dysfunction. These complications have long-term effects on the patient’s condition and can be expensive to manage. The requirement of well-rounded training for perfusionists and surgical teams can restrain market growth. The high expenditure on pediatric perfusion systems is the main factor hampering market growth. The high expenses related to complicated cardiac surgery and perfusion may limit access to care for families without sufficient insurance coverage or in less developed nations. These factors restrain the growth of the pediatric perfusion market during the forecast period.

 

Market Segmentation

The global pediatric perfusion systems market share is classified into product, application, and end-user.

• The oxygenators segment is anticipated to hold the largest share of the global pediatric perfusion systems market during the forecast period.   

On the basis of the product, the global pediatric perfusion systems market is divided into oxygenators, cannulas and catheters, blood pumps, and arterial filters. Among these, the oxygenators segment is anticipated to hold the largest share of the global pediatric perfusion systems market during the forecast period. Oxygenators play an important role in the cardiopulmonary bypass (CPB) process, where they eliminate carbon dioxide from the blood by permeating it with oxygen, effectively copying the respiratory function of the lungs. This function of oxygenators secures enough blood oxygenation, assisting life throughout the body and its organs, which is one of the main driving factors in the market. Additionally, manufacturers and companies continuously develop and launch advanced and novel oxygenators to improve the results for patients.

 

• The cardiac surgeries segment is expected to hold the largest share of the global pediatric perfusion systems market during the forecast period.   

On the basis of the application, the global pediatric perfusion systems are divided into cardiac surgeries and organ transplantation. Among these, the cardiac surgeries segment is expected to hold the largest share of the global pediatric perfusion systems market during the forecast period. Pediatric cardiac procedures are highly sought after to treat acquired heart disorders such as infections, cardiomyopathies, and rheumatic heart disease, even though congenital heart problems remain their main cause. The cases of these conditions contribute to the overall requirement for cardiac interventions in pediatric population. In addition, rising awareness regarding pediatric cardiac problems and efforts to improve healthcare availability around the world contribute to the rising demand for pediatric cardiac surgeries. Initiatives aimed at growing treatment access, particularly in developing countries, propel the requirement for complete cardiac care, thus supporting the advancement of the segment.

 

• The hospitals segment is anticipated to hold the largest share of the global pediatric perfusion systems market during the forecast period.   

On the basis of the end-user, the global pediatric perfusion systems market is divided into hospitals and cardiac centers. Among these, the hospitals segment is anticipated to hold the largest share of the global pediatric perfusion systems market during the forecast period. The increasing cases of individuals related to cardiac and respiratory diseases and the increasing number of organ transplantation methods in hospitals propel market growth. The demand for pediatric cardiac operations, which are generally caused by congenital heart defects or cardiac disease at birth, drives operational volumes in hospitals. In children, an advanced perfusion system is needed to ensure a safe and successful cardiac operation in the pediatric population. Upgraded safety, monitoring abilities, and higher oxygenation assistance are inviting hospitals searching for the most recent advancements in pediatric cardiac care.

 

Regional Segment Analysis of the Global Pediatric Perfusion Systems Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the global pediatric perfusion systems market over the predicted timeframe.

 

Get more details on this report -

Request Free Sample PDF

 

North America is anticipated to hold the largest share of the global pediatric perfusion systems market over the predicted timeframe. A number of top medical device companies are based in the U.S. and Canada and spend heavily on research and development to innovate new pediatric perfusion systems. Hospitals in this region are well-equipped with novel cardiac facilities and a well-trained perfusionist team to expertly conduct pediatric heat surgeries, fueling the need for pediatric perfusion systems. Increasing awareness related to congenital heart disorders and increasing pediatric cardiac surgeries have driven the growth of the pediatric perfusion systems market. In addition, North America is a home for advanced technology and medical research. Improvements in perfusion technology, research activities, and partnerships with academic institutions and industry players all contribute to the development of this region. These factors are driving the growth of the pediatric perfusion systems market over the predicted timeframe.

 

Asia Pacific is anticipated to grow at the fastest rate in the global pediatric perfusion systems market over the predicted timeframe. The fastest economic growth, improving healthcare facilities, and increasing medical tourism in nations such as India, China, and Japan are propelling the growth of the market. There is a rise in the number of cases of treatable congenital heart disease because of better diagnosis and examination. These inspiring hospitals are building up their pediatric cardiology departments with advanced equipment, like heart-lung machines. Additionally, rising government expenditure for pediatric healthcare and capabilities to spread awareness will help grow the market. These factors are driving the growth of the pediatric perfusion systems market over the predicted timeframe.  

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global pediatric perfusion systems market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• LivaNova PLC
• BL Lifesciences
• EUROSETS
• Medtronic
• Cardinal Health
• Nonin
• Stryker Corporation
• Getinge AB
• Terumo Cardiovascular Systems Corporation
• Edwards Lifesciences Corporation
• GENERAL ELECTRIC COMPANY
• Fluigent
• Koninkliijke N.V.
• Philips Healthcare
• Sorin Group
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Developments

• In March 2023, LivaNova PLC, a medical technology and innovation company, introduced that it had received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz Heart-Lung Machine (HLM). LivaNOva PLC begins the commercial announcement of Essenz in the U.S.

 

• In December 2021, Medtronic plc introduced that the FDA permit 510(k) clearance for their INVOS 7100 oximetry device for children aged birth to 18. It detects huge signals to help pediatric physicians make instant decisions about hemodynamic management, ventilation, and resuscitation for preterm babies, neonates, children, and other patients treated by pediatric doctors.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global pediatric perfusion systems market based on the below-mentioned segments: 

 

Global Pediatric Perfusion Systems Market, By Product

• Oxygenators
• Cannulas and Catheters
• Blood Pumps
• Arterial Filters

 

Global Pediatric Perfusion Systems Market, By Application

• Cardiac Surgeries
• Organ Transplantation

 

Global Pediatric Perfusion Systems Market, By End-User

• Hospitals
• Cardiac Centers

 

Global Pediatric Perfusion Systems Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa